HR
PPH icon

Howe & Rusling’s VanEck Pharmaceutical ETF PPH Stock Holding History

Howe & Rusling’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-100
Closed -$6K – 926
2014
Q2 		$6K Hold
100
– – ﹤0.01% 590
2014
Q1 		$6K Buy
100
+25
+33% +$1.41K ﹤0.01% 643
2013
Q4 		$4K Sell
75
-11,220
-99% -$568K ﹤0.01% 635
2013
Q3 		$542K Sell
11,295
-1,465
-11% -$69.5K 0.2% 82
2013
Q2 		$580K Buy
+12,760
New +$590K 0.16% 99

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Howe & Rusling's PPH Position: Q3 2014 in Review

Howe & Rusling sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2014, closing a stake of 100 shares — an estimated $6K sold.

Howe & Rusling first reported a position in PPH in Q2 2013 and held it in 5 quarters. The position peaked at $580K in Q2 2013. 49 funds tracked by Wall St. Rank hold PPH as of Q3 2014.

  • Howe & Rusling reported no remaining VanEck Pharmaceutical ETF position as of Q3 2014 after selling out during the quarter.
  • Howe & Rusling sold 100 VanEck Pharmaceutical ETF shares in Q3 2014, an estimated $6K.
  • Howe & Rusling first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 5 quarters.
  • Howe & Rusling's VanEck Pharmaceutical ETF position peaked at $580K in Q2 2013.
  • 49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2014.

Based on Howe & Rusling's 13F filing for Q3 2014, filed 31 Oct 2014.